nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antioxidant treatment of tardive dyskinesia
|
Rotrosen, John |
|
1996 |
55 |
1-2 |
p. 77-81 5 p. |
artikel |
2 |
Decreased tyrosine transport in fibroblasts from schizophrenics: Implications for membrane pathology
|
Ramchand, C.N. |
|
1996 |
55 |
1-2 |
p. 59-64 6 p. |
artikel |
3 |
Dyskinesias and their treatment with essential fatty acids: a review
|
Vaddadi, Krishna |
|
1996 |
55 |
1-2 |
p. 89-94 6 p. |
artikel |
4 |
Editorial Board
|
|
|
1996 |
55 |
1-2 |
p. i- 1 p. |
artikel |
5 |
Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation
|
Peet, M. |
|
1996 |
55 |
1-2 |
p. 71-75 5 p. |
artikel |
6 |
Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933
|
Nilsson, Agneta |
|
1996 |
55 |
1-2 |
p. 83-87 5 p. |
artikel |
7 |
Free radical pathology in schizophrenia: a review
|
Reddy, Ravinder D. |
|
1996 |
55 |
1-2 |
p. 33-43 11 p. |
artikel |
8 |
Heat stress lipids and schizophrenia
|
Bates, P.R. |
|
1996 |
55 |
1-2 |
p. 101-107 7 p. |
artikel |
9 |
Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia
|
Yao, J.K. |
|
1996 |
55 |
1-2 |
p. 21-26 6 p. |
artikel |
10 |
In memoriam: Sukdeb Mukherjee MD, 1946–1995
|
Horrobin, David |
|
1996 |
55 |
1-2 |
p. 1- 1 p. |
artikel |
11 |
Membrane fatty acids, niacin flushing and clinical parameters
|
Glen, A.I.M. |
|
1996 |
55 |
1-2 |
p. 9-15 7 p. |
artikel |
12 |
Oxidative injury and potential use of antioxidants in schizophrenia
|
Mahadik, S.P. |
|
1996 |
55 |
1-2 |
p. 45-54 10 p. |
artikel |
13 |
Phospholipase A2 and the hypofrontality hypothesis of schizophrenia
|
Gattaz, Wagner F. |
|
1996 |
55 |
1-2 |
p. 109-113 5 p. |
artikel |
14 |
Phospholipases: in search of a genetic base of schizophrenia
|
Hudson, Craig J. |
|
1996 |
55 |
1-2 |
p. 119-122 4 p. |
artikel |
15 |
31P magnetic responance spectroscopy studies in schizophrenia
|
Williamson, P.C. |
|
1996 |
55 |
1-2 |
p. 115-118 4 p. |
artikel |
16 |
Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients
|
Ramchand, C.N. |
|
1996 |
55 |
1-2 |
p. 27-31 5 p. |
artikel |
17 |
Schizophrenia as a membrane lipid disorder which is expressed throughout the body
|
Horrobin, David F. |
|
1996 |
55 |
1-2 |
p. 3-7 5 p. |
artikel |
18 |
The lipid membrane hypothesis of schizophrenia: implications for possible clinical breath tests
|
Dodd, G.H. |
|
1996 |
55 |
1-2 |
p. 95-99 5 p. |
artikel |
19 |
The niacin challenge test in schizophrenia: past, present and future
|
Lin, A. |
|
1996 |
55 |
1-2 |
p. 17-19 3 p. |
artikel |
20 |
Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia
|
Wiesel, F.-A. |
|
1996 |
55 |
1-2 |
p. 55-58 4 p. |
artikel |
21 |
Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls
|
Mahadik, S.P. |
|
1996 |
55 |
1-2 |
p. 65-70 6 p. |
artikel |